Shuhong Wu Selected Research

Paclitaxel (Taxol)

3/2008	Design, synthesis, cytoselective toxicity, structure-activity relationships, and pharmacophore of thiazolidinone derivatives targeting drug-resistant lung cancer cells.
7/2005	P-glycoprotein-independent apoptosis induction by a novel synthetic compound, MMPT [5-[(4-methylphenyl)methylene]-2-(phenylamino)-4(5H)-thiazolone].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuhong Wu Research Topics

Disease

32	Neoplasms (Cancer) 12/2023 - 02/2004
12	Lung Neoplasms (Lung Cancer) 01/2019 - 07/2005
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020 - 02/2006
7	Colonic Neoplasms (Colon Cancer) 03/2006 - 03/2004
4	Carcinogenesis 11/2020 - 06/2006
3	Nasopharyngeal Carcinoma 01/2024 - 11/2020
3	Inflammation (Inflammations) 05/2023 - 03/2004
3	Allergic Rhinitis 12/2021 - 10/2018
3	Leukemia 11/2017 - 01/2015
2	Rheumatoid Arthritis 10/2018 - 01/2016
2	Kidney Neoplasms (Kidney Cancer) 01/2011 - 04/2010
1	Autoimmune Diseases (Autoimmune Disease) 12/2023
1	Heart Failure 03/2023
1	Myocardial Infarction 03/2023
1	Knee Osteoarthritis 08/2022
1	Arthritis (Polyarthritis) 08/2022
1	Epstein-Barr Virus Infections 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Neoplasm Metastasis (Metastasis) 11/2020
1	Aneuploidy (Aneuploid) 01/2019
1	Adenocarcinoma of Lung 10/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2017

Drug/Important Bio-Agent (IBA)

11	Antineoplastic Agents (Antineoplastics)IBA 01/2015 - 02/2004
6	Biomarkers (Surrogate Marker)IBA 11/2023 - 06/2009
5	Proteins (Proteins, Gene)FDA Link 05/2023 - 07/2005
5	1- ((3- chlorophenyl)methyl)- 1H- indole- 3- carbinolIBA 11/2017 - 01/2011
4	NSC-741909IBA 01/2011 - 06/2009
3	Auranofin (Ridaura)FDA Link 01/2019 - 01/2016
3	oncrasin-1IBA 04/2011 - 09/2008
3	Phosphotransferases (Kinase)IBA 12/2010 - 03/2004
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2006 - 07/2005
3	Cytochromes c (Cytochrome c)IBA 07/2005 - 02/2004
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2021 - 03/2006
2	Thioredoxin-Disulfide ReductaseIBA 01/2019 - 01/2019
2	EnzymesIBA 01/2019 - 01/2013
2	Glutathione (Reduced Glutathione)IBA 01/2019 - 01/2019
2	ibrutinibIBA 10/2018 - 09/2014
2	GoldIBA 10/2018 - 01/2016
2	Therapeutic UsesIBA 01/2017 - 01/2002
2	Methanol (Carbinol)IBA 10/2016 - 12/2010
2	Insulin-Like PeptidesIBA 12/2013 - 01/2013
2	RNA Polymerase II (RNA Polymerase B)IBA 04/2011 - 01/2011
2	indoleIBA 12/2010 - 02/2009
2	ras ProteinsIBA 02/2009 - 09/2008
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2008 - 07/2005
2	Caspase 9IBA 07/2005 - 02/2004
2	Proteasome InhibitorsIBA 07/2005 - 07/2005
2	Bortezomib (Velcade)FDA Link 07/2005 - 07/2005
2	Caspase 3 (Caspase-3)IBA 07/2005 - 02/2004
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 07/2005 - 02/2004
2	Small Interfering RNA (siRNA)IBA 04/2005 - 03/2005
2	2- ((3- (2,3- dichlorophenoxy)propyl)amino)ethanolIBA 06/2004 - 02/2004
2	Ethanol (Ethyl Alcohol)IBA 06/2004 - 02/2004
1	erastinIBA 01/2024
1	DNA (Deoxyribonucleic Acid)IBA 11/2023
1	Transcription Factors (Transcription Factor)IBA 05/2023
1	MicroRNAs (MicroRNA)IBA 05/2023
1	RG7388IBA 01/2022
1	CytokinesIBA 12/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2020
1	Small Nucleolar RNA (snoRNA)IBA 11/2020
1	Long Noncoding RNAIBA 11/2020
1	osimertinibIBA 11/2020
1	matrigelIBA 06/2020
1	OvalbuminIBA 01/2020
1	trametinibIBA 01/2020
1	navitoclaxIBA 01/2020
1	Glutamate-Cysteine LigaseIBA 01/2019
1	quinone (benzoquinone)IBA 01/2019
1	Glutathione Reductase (Glutathione-Disulfide Reductase)IBA 01/2019
1	NAD (NADH)IBA 01/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2019
1	ThioredoxinsIBA 01/2019
1	Chemokine ReceptorsIBA 10/2018
1	Immunologic Factors (Immunomodulators)IBA 10/2018
1	Eosinophil Granule ProteinsIBA 10/2018
1	LigandsIBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	AntibodiesIBA 01/2017
1	SulfotransferasesIBA 01/2015
1	oncrasin-266IBA 10/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2014
1	Agammaglobulinaemia Tyrosine KinaseIBA 09/2014
1	ErbB Receptors (EGF Receptor)IBA 09/2014
1	Dasatinib (BMS 354825)FDA Link 12/2013
1	ImmunosorbentsIBA 01/2013
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 05/2012
1	Cyclin D1IBA 01/2011
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2010
1	Protein Kinases (Protein Kinase)IBA 02/2009
1	PKC-3 proteinIBA 09/2008
1	protein kinase C lambdaIBA 09/2008

Therapy/Procedure

7	Therapeutics 01/2022 - 06/2004
3	Immunotherapy 12/2023 - 01/2017
2	Aftercare (After-Treatment) 01/2020 - 06/2009
1	Organ Transplantation 12/2023
1	First Aid (Aids, First) 03/2023
1	Osteotomy 08/2022
1	Radiotherapy 01/2019